DOLLY SUD - Academia.edu (original) (raw)

Papers by DOLLY SUD

Research paper thumbnail of Medicines optimization and illness management research using dyads

Research paper thumbnail of The impact of providing care for physical health in severe mental illness on informal carers: a qualitative study

Background People with severe mental illness (SMI) e.g., schizophrenia are at a substantially hig... more Background People with severe mental illness (SMI) e.g., schizophrenia are at a substantially higher risk of premature death, in that they die 10–20 years earlier than the general population. Cardiovascular disease (CVD) and diabetes are the main potentially avoidable contributors to early death. Aims To explore the impacts of providing care for physical health in severe mental illness on informal carers. Method Thematic analysis of semi-structured interviews with eight informal carers of people with SMI in the UK national health services. Results Informal carers played an active part in the management of the patient’s conditions and shared their illness experience. Carers provided both emotional and practical involvement and informal carers’ own lives were affected in ways that were sometimes deeply profound. Informal carers were involved in both ‘looking after’ the patient from the perspective of doing practical tasks such as collecting dispensed medication from a community pharma...

Research paper thumbnail of Medication management in M inority, A sian and B lack ethnic older people in the United Kingdom: A mixed‐studies systematic review

Journal of Clinical Pharmacy and Therapeutics

Research paper thumbnail of Additional file 1 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 1. PRISMA-2009-Checklist-MS-Word.

Research paper thumbnail of Additional file 3 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 3. Effective Practice and Organisation of Care (EPOC) Taxonomy of interventions.

Research paper thumbnail of Additional file 2 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 2. Supplementary material relating to systematic review and quality assessment.

Research paper thumbnail of The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness

Health Expectations, 2021

Background: Informal carers play an important role in the care of patients with mental illness. L... more Background: Informal carers play an important role in the care of patients with mental illness. Little is known of the relationship experience of the patient and their informal carer (caring dyad) as the context for the intersection between physical and mental health. Aim: This study aimed to explore the impact of comorbid cardiometabolic risk (CMR), metabolic syndrome (MetS) and related diseases and severe mental illness (SMI) on the caring dyad. Design: Between October 2018 and March 2020, we conducted 11 in-depth semistructured interviews across 6 adult caring dyads, interviewing each individual separately. Setting: Dyads were recruited within the United Kingdom; informal carers were nominated by the patient as a person who provided a significant amount of support. Variable Being Studied: Participants were asked about the impacts of illness and caring on daily life. Data Analysis: Data were analysed at the dyad level using thematic analysis, comparing and contrasting responses from each individual. Results: Themes were identified: enhanced closeness, dissonance and balance within the caring dyad. Discussion and Conclusions: This study uses a particular population of patients with comorbid CMR factors, MetS and related diseases and SMI and their informal carers to explore the relevance and utility of caring dyads as an analytical framework to inform practice and policy. Future interventions should consider factors impacting on dyadic relationships to formulate effective and sustainable dyadic care and This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Research paper thumbnail of Challenge of optimising medication in people with severe mental illness

BMJ Quality & Safety, 2021

Research paper thumbnail of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Systematic Reviews, 2021

Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened ... more Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified usin...

Research paper thumbnail of Cardiometabolic risk, metabolic syndrome, and related diseases in severe mental illness: the role of pharmacy in the lived experience of patients

Background: The thesis explores the role of pharmacy in the lived experience of patients with sev... more Background: The thesis explores the role of pharmacy in the lived experience of patients with severe mental illness (SMI) who experience excess morbidity and mortality due to cardiometabolic risk (CMR), metabolic syndrome (MetS) and related diseases. Aims and objectives: To understand and explain the role of pharmacy in providing care for CMR, MetS and related diseases in patients with SMI; achieved by 1. systematically reviewing the published evidence 2. exploring and document the views, perceptions, and experiences of patients with SMI, their informal carers, caring dyads (caring dyad defined here as a patient and their informal carer), care and pharmacy professionals 3. providing strategic recommendations for pharmacy for clinical practice, policy, and research to improve care. Methods, results, and key findings: To address research objective 1. a systematic review of 33 articles found that face-to-face interactions of pharmacists with others consistently and significantly improv...

Research paper thumbnail of Challenge of optimising medication in people with severe mental illness

Research paper thumbnail of The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness

Research paper thumbnail of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Systematic Reviews

Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened ... more Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified usin...

Research paper thumbnail of Utilising dyads in medicines optimisation and illness management research

Research in Social and Administrative Pharmacy

Research paper thumbnail of A guide to prescribing anti-dementia medication

Nursing times

This article outlines a good practice guide to prescribing anti-dementia medication developed joi... more This article outlines a good practice guide to prescribing anti-dementia medication developed jointly by a lead nurse for memory services and a clinical pharmacist. The guide brings together current evidence to produce a concise prescribing guideline for practitioners.

Research paper thumbnail of Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

International journal of clinical pharmacy, 2016

Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipola... more Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be l...

Research paper thumbnail of Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

International journal of clinical pharmacy, 2016

Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipola... more Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be l...

Research paper thumbnail of Medicines optimization and illness management research using dyads

Research paper thumbnail of The impact of providing care for physical health in severe mental illness on informal carers: a qualitative study

Background People with severe mental illness (SMI) e.g., schizophrenia are at a substantially hig... more Background People with severe mental illness (SMI) e.g., schizophrenia are at a substantially higher risk of premature death, in that they die 10–20 years earlier than the general population. Cardiovascular disease (CVD) and diabetes are the main potentially avoidable contributors to early death. Aims To explore the impacts of providing care for physical health in severe mental illness on informal carers. Method Thematic analysis of semi-structured interviews with eight informal carers of people with SMI in the UK national health services. Results Informal carers played an active part in the management of the patient’s conditions and shared their illness experience. Carers provided both emotional and practical involvement and informal carers’ own lives were affected in ways that were sometimes deeply profound. Informal carers were involved in both ‘looking after’ the patient from the perspective of doing practical tasks such as collecting dispensed medication from a community pharma...

Research paper thumbnail of Medication management in M inority, A sian and B lack ethnic older people in the United Kingdom: A mixed‐studies systematic review

Journal of Clinical Pharmacy and Therapeutics

Research paper thumbnail of Additional file 1 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 1. PRISMA-2009-Checklist-MS-Word.

Research paper thumbnail of Additional file 3 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 3. Effective Practice and Organisation of Care (EPOC) Taxonomy of interventions.

Research paper thumbnail of Additional file 2 of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Additional file 2. Supplementary material relating to systematic review and quality assessment.

Research paper thumbnail of The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness

Health Expectations, 2021

Background: Informal carers play an important role in the care of patients with mental illness. L... more Background: Informal carers play an important role in the care of patients with mental illness. Little is known of the relationship experience of the patient and their informal carer (caring dyad) as the context for the intersection between physical and mental health. Aim: This study aimed to explore the impact of comorbid cardiometabolic risk (CMR), metabolic syndrome (MetS) and related diseases and severe mental illness (SMI) on the caring dyad. Design: Between October 2018 and March 2020, we conducted 11 in-depth semistructured interviews across 6 adult caring dyads, interviewing each individual separately. Setting: Dyads were recruited within the United Kingdom; informal carers were nominated by the patient as a person who provided a significant amount of support. Variable Being Studied: Participants were asked about the impacts of illness and caring on daily life. Data Analysis: Data were analysed at the dyad level using thematic analysis, comparing and contrasting responses from each individual. Results: Themes were identified: enhanced closeness, dissonance and balance within the caring dyad. Discussion and Conclusions: This study uses a particular population of patients with comorbid CMR factors, MetS and related diseases and SMI and their informal carers to explore the relevance and utility of caring dyads as an analytical framework to inform practice and policy. Future interventions should consider factors impacting on dyadic relationships to formulate effective and sustainable dyadic care and This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Research paper thumbnail of Challenge of optimising medication in people with severe mental illness

BMJ Quality & Safety, 2021

Research paper thumbnail of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Systematic Reviews, 2021

Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened ... more Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified usin...

Research paper thumbnail of Cardiometabolic risk, metabolic syndrome, and related diseases in severe mental illness: the role of pharmacy in the lived experience of patients

Background: The thesis explores the role of pharmacy in the lived experience of patients with sev... more Background: The thesis explores the role of pharmacy in the lived experience of patients with severe mental illness (SMI) who experience excess morbidity and mortality due to cardiometabolic risk (CMR), metabolic syndrome (MetS) and related diseases. Aims and objectives: To understand and explain the role of pharmacy in providing care for CMR, MetS and related diseases in patients with SMI; achieved by 1. systematically reviewing the published evidence 2. exploring and document the views, perceptions, and experiences of patients with SMI, their informal carers, caring dyads (caring dyad defined here as a patient and their informal carer), care and pharmacy professionals 3. providing strategic recommendations for pharmacy for clinical practice, policy, and research to improve care. Methods, results, and key findings: To address research objective 1. a systematic review of 33 articles found that face-to-face interactions of pharmacists with others consistently and significantly improv...

Research paper thumbnail of Challenge of optimising medication in people with severe mental illness

Research paper thumbnail of The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness

Research paper thumbnail of The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review

Systematic Reviews

Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened ... more Background Individuals with severe mental illness, e.g. schizophrenia have up to a 20% shortened life expectancy compared to the general population. Cardiovascular disease, due to cardiometabolic risk and metabolic syndrome, accounts for most of this excess mortality. A scoping search revealed that there has not been a review of published studies on the role of pharmacy in relation to cardiometabolic risk, metabolic syndrome and related diseases (e.g. type 2 diabetes) in individuals with severe mental illness. Methods A mixed-methods systematic review was performed. Eleven databases were searched using a comprehensive search strategy to identify English-language studies where pharmacy was involved in an intervention for cardiometabolic risk, metabolic syndrome or related diseases in severe mental illness in any study setting from any country of origin. First, a mapping review was conducted. Then, implementation strategies used to implement the study intervention were classified usin...

Research paper thumbnail of Utilising dyads in medicines optimisation and illness management research

Research in Social and Administrative Pharmacy

Research paper thumbnail of A guide to prescribing anti-dementia medication

Nursing times

This article outlines a good practice guide to prescribing anti-dementia medication developed joi... more This article outlines a good practice guide to prescribing anti-dementia medication developed jointly by a lead nurse for memory services and a clinical pharmacist. The guide brings together current evidence to produce a concise prescribing guideline for practitioners.

Research paper thumbnail of Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

International journal of clinical pharmacy, 2016

Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipola... more Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be l...

Research paper thumbnail of Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

International journal of clinical pharmacy, 2016

Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipola... more Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be l...